American Society of Hematology

2016 ASH® Meeting on Hematologic Malignancies

September 16-17, 2016
Fairmont Chicago, Millennium Park, Chicago, IL

 Add to calendar 09/16/2016 07:00 AM09/17/2016 08:00 PMASH Meeting on Hematologic MalignanciesHear the top experts in hematologic malignancies discuss the latest developments in clinical care and find answers to your most challenging patient care questions.Fairmont Chicago, Millennium Park, Chicago, ILMM/DD/YYYY129600
     Get email updates    Spread the word

Advance registration is open through September 3, 2016.

Register now

Hear Dr. Ken Anderson and Dr. Martin Tallman discuss this year's meeting in the latest Hematologist podcast:

Attend the 2016 ASH Meeting on Hematologic Malignancies to hear world-class experts in hematologic malignancies discuss the latest developments in clinical care, and learn how experts in the field treat their own patients based on the available data.

The majority of the program content will be structured as "How I Treat" sessions on core malignancies, including leukemia, lymphoma, myelodysplastic syndromes, myeloma, and myeloproliferative neoplasms. Each presentation will showcase the speaker's evidence-based treatment approaches, ranging from standard of care, specialized disease complications, and novel agent discussions. The meeting will also feature topic-based panel discussions which will allow participants to get answers to their most challenging patient care questions.

Key Dates

Advance Registration DeadlineSeptember 3, 2016
Consultative Hematology CourseSeptember 15, 2016
Free CME MDS SummitSeptember 15, 2016

Program Co-Chairs

Kenneth C_ Anderson, MD

Kenneth C. Anderson, MD
Dana-Farber Cancer

Joseph M_ Connors, MD

Joseph M. Connors, MD
Vancouver Clinic, British Columbia Cancer Agency

Martin S_ Tallman, MD

Martin S. Tallman, MD
Memorial Sloan-Kettering Cancer Center

Program Planning Committee

  • Kenneth C. Anderson, MD, Dana-Farber Cancer Institute
  • Hetty Carraway, MD, Cleveland Clinic
  • Joseph M. Connors, MD, British Columbia Cancer Agency
  • Brad Kahl, MD, Washington University in St. Louis
  • Ruben A. Mesa, MD, Mayo Clinic
  • Wendy Stock, MD, University of Chicago
  • Martin S. Tallman, MD, Memorial Sloan Kettering Cancer Center

Corporate Support

Premier Supporters

  • AbbVie, Inc.
  • Amgen, Inc.
  • Celgene Corporation

Lead Supporters

  • Incyte Corporation
  • Pharmacyclics LLC and Janssen Biotech, Inc.
  • Seattle Genetics
  • Takeda Oncology
  • Teva Oncology

Other Supporters

  • Astellas Pharma US, Inc.
  • Pfizer, Inc.

If your company is interested in sponsoring and/or exhibiting at this meeting, contact Thelma Barnett at for more information.

back to top